Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo

Filip Zmuda, Gaurav Malviya, Adele Blair, Marie Boyd, Anthony J. Chalmers, Andrew Sutherland, Sally L. Pimlott

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Interest in nuclear imaging of poly(ADP-ribose) polymerase-1 (PARP-1) has grown in recent years due to the ability of PARP-1 to act as a biomarker for glioblastoma and increased clinical use of PARP-1 inhibitors. This study reports the identification of a lead iodinated analog 5 of the clinical PARP-1 inhibitor olaparib as a potential single-photon emission computed tomography (SPECT) imaging agent. Compound 5 was shown to be a potent PARP-1 inhibitor in cell-free and cellular assays, and it exhibited mouse plasma stability but approximately 3-fold greater intrinsic clearance when compared to olaparib. An (123)I-labeled version of 5 was generated using solid state halogen exchange methodology. Ex vivo biodistribution studies of [(123)I]-5 in mice bearing subcutaneous glioblastoma xenografts revealed that the tracer had the ability to be retained in tumour tissue and bind to PARP-1 with specificity. These findings support further investigations of [(123)I]-5 as a non-invasive PARP-1 SPECT imaging agent.

LanguageEnglish
Pages8683-8693
Number of pages11
JournalJournal of Medicinal Chemistry
Volume58
Issue number21
Early online date15 Oct 2015
DOIs
Publication statusPublished - 12 Nov 2015

Fingerprint

Poly(ADP-ribose) Polymerases
Single photon emission computed tomography
Glioblastoma
Single-Photon Emission-Computed Tomography
Imaging techniques
Bearings (structural)
Plasma stability
Halogens
Biomarkers
Poly (ADP-Ribose) Polymerase-1
Heterografts
Tumors
Assays
Tissue
Poly(ADP-ribose) Polymerase Inhibitors
Neoplasms

Keywords

  • nuclear imaging
  • radioiodinated tracer
  • single-photon emission computed tomography

Cite this

Zmuda, Filip ; Malviya, Gaurav ; Blair, Adele ; Boyd, Marie ; Chalmers, Anthony J. ; Sutherland, Andrew ; Pimlott, Sally L. / Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo. In: Journal of Medicinal Chemistry. 2015 ; Vol. 58, No. 21. pp. 8683-8693.
@article{85b1a51397a2440a9f72515af08f6084,
title = "Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo",
abstract = "Interest in nuclear imaging of poly(ADP-ribose) polymerase-1 (PARP-1) has grown in recent years due to the ability of PARP-1 to act as a biomarker for glioblastoma and increased clinical use of PARP-1 inhibitors. This study reports the identification of a lead iodinated analog 5 of the clinical PARP-1 inhibitor olaparib as a potential single-photon emission computed tomography (SPECT) imaging agent. Compound 5 was shown to be a potent PARP-1 inhibitor in cell-free and cellular assays, and it exhibited mouse plasma stability but approximately 3-fold greater intrinsic clearance when compared to olaparib. An (123)I-labeled version of 5 was generated using solid state halogen exchange methodology. Ex vivo biodistribution studies of [(123)I]-5 in mice bearing subcutaneous glioblastoma xenografts revealed that the tracer had the ability to be retained in tumour tissue and bind to PARP-1 with specificity. These findings support further investigations of [(123)I]-5 as a non-invasive PARP-1 SPECT imaging agent.",
keywords = "nuclear imaging, radioiodinated tracer, single-photon emission computed tomography",
author = "Filip Zmuda and Gaurav Malviya and Adele Blair and Marie Boyd and Chalmers, {Anthony J.} and Andrew Sutherland and Pimlott, {Sally L.}",
year = "2015",
month = "11",
day = "12",
doi = "10.1021/acs.jmedchem.5b01324",
language = "English",
volume = "58",
pages = "8683--8693",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "21",

}

Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo. / Zmuda, Filip; Malviya, Gaurav; Blair, Adele; Boyd, Marie; Chalmers, Anthony J.; Sutherland, Andrew; Pimlott, Sally L.

In: Journal of Medicinal Chemistry, Vol. 58, No. 21, 12.11.2015, p. 8683-8693.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Synthesis and evaluation of a radioiodinated tracer with specificity for poly(ADP-ribose) polymerase-1 (PARP-1) in vivo

AU - Zmuda, Filip

AU - Malviya, Gaurav

AU - Blair, Adele

AU - Boyd, Marie

AU - Chalmers, Anthony J.

AU - Sutherland, Andrew

AU - Pimlott, Sally L.

PY - 2015/11/12

Y1 - 2015/11/12

N2 - Interest in nuclear imaging of poly(ADP-ribose) polymerase-1 (PARP-1) has grown in recent years due to the ability of PARP-1 to act as a biomarker for glioblastoma and increased clinical use of PARP-1 inhibitors. This study reports the identification of a lead iodinated analog 5 of the clinical PARP-1 inhibitor olaparib as a potential single-photon emission computed tomography (SPECT) imaging agent. Compound 5 was shown to be a potent PARP-1 inhibitor in cell-free and cellular assays, and it exhibited mouse plasma stability but approximately 3-fold greater intrinsic clearance when compared to olaparib. An (123)I-labeled version of 5 was generated using solid state halogen exchange methodology. Ex vivo biodistribution studies of [(123)I]-5 in mice bearing subcutaneous glioblastoma xenografts revealed that the tracer had the ability to be retained in tumour tissue and bind to PARP-1 with specificity. These findings support further investigations of [(123)I]-5 as a non-invasive PARP-1 SPECT imaging agent.

AB - Interest in nuclear imaging of poly(ADP-ribose) polymerase-1 (PARP-1) has grown in recent years due to the ability of PARP-1 to act as a biomarker for glioblastoma and increased clinical use of PARP-1 inhibitors. This study reports the identification of a lead iodinated analog 5 of the clinical PARP-1 inhibitor olaparib as a potential single-photon emission computed tomography (SPECT) imaging agent. Compound 5 was shown to be a potent PARP-1 inhibitor in cell-free and cellular assays, and it exhibited mouse plasma stability but approximately 3-fold greater intrinsic clearance when compared to olaparib. An (123)I-labeled version of 5 was generated using solid state halogen exchange methodology. Ex vivo biodistribution studies of [(123)I]-5 in mice bearing subcutaneous glioblastoma xenografts revealed that the tracer had the ability to be retained in tumour tissue and bind to PARP-1 with specificity. These findings support further investigations of [(123)I]-5 as a non-invasive PARP-1 SPECT imaging agent.

KW - nuclear imaging

KW - radioiodinated tracer

KW - single-photon emission computed tomography

UR - http://www.scopus.com/inward/record.url?scp=84947475148&partnerID=8YFLogxK

U2 - 10.1021/acs.jmedchem.5b01324

DO - 10.1021/acs.jmedchem.5b01324

M3 - Article

VL - 58

SP - 8683

EP - 8693

JO - Journal of Medicinal Chemistry

T2 - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 21

ER -